Faron Pharmaceuticals Oy (LON:FARN)‘s stock had its “buy” rating restated by equities researchers at Panmure Gordon in a research note issued to investors on Monday, October 2nd.

Faron Pharmaceuticals Oy (LON:FARN) remained flat at GBX 840.00 during trading on Monday. The company’s stock had a trading volume of 284 shares. The stock’s market capitalization is GBX 229.24 million. Faron Pharmaceuticals Oy has a 12 month low of GBX 245.00 and a 12 month high of GBX 900.00. The firm has a 50-day moving average price of GBX 791.96 and a 200 day moving average price of GBX 727.97.

TRADEMARK VIOLATION NOTICE: This story was reported by Marea Informative and is the sole property of of Marea Informative. If you are viewing this story on another publication, it was stolen and reposted in violation of U.S. & international copyright & trademark laws. The correct version of this story can be viewed at http://www.mareainformativa.com/faron-pharmaceuticals-oys-farn-buy-rating-reiterated-at-panmure-gordon/116389/.

In related news, insider Jonathan Knowles bought 63,000 shares of the company’s stock in a transaction that occurred on Friday, September 8th. The shares were purchased at an average cost of GBX 725 ($9.53) per share, with a total value of £456,750 ($600,512.75). Also, insider Frank Armstrong acquired 1,250 shares of the stock in a transaction on Wednesday, October 11th. The shares were acquired at an average cost of GBX 800 ($10.52) per share, for a total transaction of £10,000 ($13,147.52).

Faron Pharmaceuticals Oy Company Profile

Receive News & Stock Ratings for Faron Pharmaceuticals Oy Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Faron Pharmaceuticals Oy and related stocks with our FREE daily email newsletter.